D. Shames

Myocardial perfusion scintigraphy in patients with mitral valve prolapse: Its advantage over stress electrocardiography in diagnosing associated coronary artery disease and its implications for the etiology of chest pain.

Barry M. Massie, E H Botvinick, D. Shames et al. · Circulation · 1978 · 61 citations

Heart Failure, Radiology, Mitral Valve Prolapse +15

OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study

David P. Carbone, J. Lee, Mark G. Kris et al. · Journal of Thoracic Oncology · 2021 · 38 citations · Full text

Medicine, Immunology, Pathology +9

1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC

Mark G. Kris, Jessica M. Grindheim, Jamie E. Chaft et al. · Annals of Oncology · 2021 · 34 citations

Surgical Oncology, Tumour Dna, Medicine +5

Phase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naïve NSCLC: Initial results from the ALK+ cohort

Shirish M. Gadgeel, Tony Mok, Solange Peters et al. · Annals of Oncology · 2019 · 33 citations · Full text

Treatment-naïve Nsclc, Oncology, Clinical Endpoint +9

1265P IMpower150: A post hoc analysis of efficacy outcomes in patients with KRAS, STK11 and KEAP1 mutations

Howard West, Federico Cappuzzo, Martin Reck et al. · Annals of Oncology · 2020 · 18 citations

Keap1 Mutations, Genetic Disorder, Medicine +10